| BSE: 500302 | Sector: Health care |
| NSE: PEL | ISIN Code: INE140A01024 |
| BSE 10:33 | 14 Nov | 2277.45 |
-16.30 (-0.71%) |
OPEN
2297.00 |
HIGH
2316.35 |
LOW
2265.00 |
| NSE 10:24 | 14 Nov | 2272.40 |
-16.80 (-0.73%) |
OPEN
2291.00 |
HIGH
2315.00 |
LOW
2262.00 |
| OPEN | 2297.00 |
| PREVIOUS CLOSE | 2293.75 |
| VOLUME | 8476 |
| 52-Week high | 3302.55 |
| 52-Week low | 1796.75 |
| P/E | 49.06 |
| Mkt Cap.(Rs cr) | 41,609 |
| Buy Price | 2273.50 |
| Buy Qty | 81.00 |
| Sell Price | 2277.20 |
| Sell Qty | 12.00 |
Piramal Enterprises Limited (PEL) erstwhile Piramal Healthcare Limited is the flagship company of the Piramal Group led by Ajay Piramal. Piramal Enterprises Limited (PEL) is one of India's large diversified companies with a presence in Financial Services Pharmaceuticals and Healthcare Insights & Analytics. The company derived around 46% of its revenue from outside India during the financial year e...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
41,609 | |
| EPS - TTM | () |
[*S] | 46.42 |
| P/E Ratio | (X) | [*S] | 49.06 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 1250.00 | |
| Latest Dividend Date | 19 Jul 2018 | ||
| Dividend Yield | (%) | 1.08 | |
| Book Value / Share | () |
[*S] | 1072.07 |
| P/B Ratio | () |
[*S] | 2.12 |
Piramal reduces lending to realty developers, looks to derisk its portfolio
There is lack of confidence in the system, not liquidity: Ajay Piramal
Piramal Enterprises denies loan defaults by Lodha, Omkar, Vatika and others
Indian tycoon Ajay Piramal weighs $1 billion contract pharma sale
Headache over for now: SC lifts ban on sale of painkiller Saridon
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Piramal Enterprises Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Intimation of Committee Meeting to be held for Consideration of Issue of Non-Convertible Debentures
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Piramal Enterprises Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Particulars ( cr) |
Sep 2018 | Sep 2017 | % Chg |
| Net Sales | 3144.1 | 2535.86 | 23.99 |
| Other Income | 56.31 | 75.39 | -25.31 |
| Total Income | 3200.41 | 2611.25 | 22.56 |
| Total Expenses | 1491.06 | 1265.97 | 17.78 |
| Operating Profit | 1709.35 | 1345.28 | 27.06 |
| Net Profit | 407.03 | 301.49 | 35.01 |
| Equity Capital | 36.2 | 34.51 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Sun Pharma.Inds. | 534.15 | -4.90 | 128158.61 |
| Aurobindo Pharma | 775.00 | 0.04 | 45407.25 |
| Cipla | 525.20 | -0.55 | 42291.73 |
| Piramal Enterp. | 2277.45 | -0.71 | 41609.01 |
| Divi's Lab. | 1539.60 | 0.65 | 40868.68 |
| Dr Reddy's Labs | 2439.45 | 0.17 | 40504.63 |
| Lupin | 844.25 | -1.04 | 38181.20 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 3.44% | 3.22% | -0.44% | -0.34% |
| 1 Month | 1.44% | 1.18% | 1.01% | 0.86% |
| 3 Month | -19.73% | -19.81% | -7.32% | -7.63% |
| 6 Month | -6.56% | -6.52% | -1.33% | -2.26% |
| 1 Year | -13.11% | -13.03% | 6.50% | 3.69% |
| 3 Year | 132.46% | 131.88% | 36.99% | 36.07% |
| Today's Low/High | 2265.00 |
|
2316.35 |
| Week Low/High | 2178.00 |
|
2336.00 |
| Month Low/High | 1796.75 |
|
2368.00 |
| YEAR Low/High | 1796.75 |
|
3303.00 |
| All TIME Low/High | 6.03 |
|
3303.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
